ZARS Pharma
Topical anesthetic lidocaine-tetracaine patch developed by ZARS Pharma launched in U.S.
Published in Health Insurance Week, July 23rd, 2006
Synera is the first topical patch approved for the prevention of pain associated with superficial venous access and superficial dermatological procedures in patients 4 months of age and older. Endo is marketing the Synera patch through its existing 70-person hospital sales force. ZARS Pharma licensed the North American sales and marketing rights to Endo earlier this year.
Synera addresses an important need in the area of topical pain management, particularly in children. According to published data, children under...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Week
More Articles from Health Insurance Week
- Finance
American Physicians Capital announces financial strength rating upgrade - Healthcare Costs
A new survey released finds that Medicare prescription drug plans are paying pharmacists promptly - Healthcare Coverage
Anthem Blue Cross and Blue Shield offers access to dental, life insurance in individual market - ARUP, U.S.
Studies from the United States, Germany and Switzerland describe new findings in atherosclerosis research - AVANIR
U.S. Food and Drug Administration informs AVANIR of revised Neurodex NDA action date - Aarhus University Hospital, Aarhus, Denmark
Sulfonylureas used in diabetes therapies appear to raise myocardial infarction risk - More from this issue of Health Insurance Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
